Release Date: 21/04/10 14:22 Summary: MOU with Ochre Management Pty Ltd now binding Price Sensitive: Yes Download Document 111.63KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%